+ 4.33
+ 1.27%
+ 2.11
+ 1.5%

Pharmadrug Dives Into Psychedelics, Buys Super Smart

May 20, 2020 6:40 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Pharmadrug Dives Into Psychedelics, Buys Super Smart

Pharmadrug Inc. (CSE:BUZZ) (OTC:LMLLF) has agreed to acquire Super Smart, a Netherlands startup geared toward psychedelics.

Terms of the deal were not disclosed.

Toronto-based Pharmadrug announced Wednesday it has entered into a non-binding letter of intent with Interrobang Ltd., which does business as Super Smart, to buy 100% of the company's issued and outstanding common shares.

The goal its to grow Pharmadrug's existing business — which is focused on cannabis distribution — into the burgeoning psychedelics, or "magic mushrooms," space.

The LOI will be replaced by a final agreement between Pharmadrug and Super Smart and will be subject to shareholder and regulatory approvals.

Super Smart is under the helm of CEO Harry Resin, a former writer for High Times. Joshua Kasakevich is the company's COO, focusing on corporate strategy, branding, advertising and retail sales.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Related Articles

PharmaDrug Dives Into DMT Research With The University Of Michigan

Pharmaceutical company PharmaDrug Inc. (PINK: LMLLF) — which focuses on cannabis, psychedelics and naturally-derived medicines — has launched a sponsored research agreement with the University of Michigan to study the psychedelic DMT. read more

Psyched: MindMed Enters Psychedelics 2.0, Mind Cure Raises $18M, Mydecine Raises $13M

Mind Cure Closes $18M Raise Mind Cure Health Inc. (CSE:MCUR) recently announced the closing of a CA$23 Million ($18.1 million) offering. read more

Cannabis Stock Gainers And Losers From February 17, 2021

GAINERS: Primo Nutraceuticals (PINK: BUGVF) shares closed up 95.16% at $0.61 read more

Cannabis Stock Gainers And Losers From February 16, 2021

GAINERS: Empower Clinics (OTC: EPWCF) shares closed up 44.65% at $0.78 read more